Ponatinib after failure of second-generation tyrosine kinase inhibitor in resistant chronic-phase chronic myeloid leukemia.

导出 OA

翻译打印收藏纠错

第一作者： Hagop M,Kantarjian

第一单位： Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

作者： Hagop M,Kantarjian ^[1] ; Elias,Jabbour ^[1] ; Michael,Deininger ^[2] ; Elisabetta,Abruzzese ^[3] ; Jane,Apperley ^[4] ; Jorge,Cortes ^[5] ; Charles,Chuah ^[6] ; Daniel J,DeAngelo ^[7] ; John,DiPersio ^[8] ; Andreas,Hochhaus ^[9] ; Jeffrey,Lipton ^[10] ; Franck E,Nicolini ^[11] ; Javier,Pinilla-Ibarz ^[12] ; Delphine,Rea ^[13] ; Gianantonio,Rosti ^[14] ; Philippe,Rousselot ^[15] ; Neil P,Shah ^[16] ; Moshe,Talpaz ^[17] ; Shouryadeep,Srivastava ^[18] ; Xiaowei,Ren ^[18] ; Michael,Mauro ^[19]

作者单位： Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[1] Division of Hematology and Oncology, Department of Medicine, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah, USA. ^[2] Division of Hematology, S. Eugenio Hospital, Tor Vergata University, Rome, Italy. ^[3] Centre for Haematology, Imperial College London, London, UK. ^[4] Georgia Cancer Center, Augusta, Georgia, USA. ^[5] Department of Haematology, Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore. ^[6] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. ^[7] Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA. ^[8] Department of Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany. ^[9] Princess Margaret Cancer Centre, Toronto, Ontario, Canada. ^[10] Centre Leon Berard, Department d'Hématologie & INSERM U1052, Equipe BMP, Niche Tumorale et Resistance, CRCL, Lyon, France. ^[11] H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA. ^[12] Department of Hematology, Hopital Saint-Louis, Paris, France. ^[13] IRST/IRCCS "Dino Amadori", Meldola, Province of Forlì-Cesena, Italy. ^[14] Hospital Mignot University de Versailles Saint-Quentin-en-Yvelines, Paris, France. ^[15] Department of Medicine (Hematology/Oncology), University of California San Francisco, San Francisco, California, USA. ^[16] Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, USA. ^[17] Takeda Development Center Americas, Inc., Lexington, Massachusetts, USA. ^[18] Memorial Sloan Kettering Cancer Center, New York, New York, USA. ^[19]